2,3,4,6-tetrachlorophenol has been researched along with Seizures in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 29 (96.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pietrafusa, N; Specchio, N; Vigevano, F | 1 |
| Abou-Khalil, B; Aboumatar, S; Bhatia, P; Biton, V; Klein, P; Krauss, GL; Rosenfeld, WE; Sperling, MR; Vossler, DG; Wechsler, R | 1 |
| Abou-Khalil, B; Aboumatar, S; Bhatia, P; Biton, V; Ferrari, L; Grall, M; Klein, P; Krauss, GL; Rosenfeld, WE; Sperling, MR; Vossler, DG; Wechsler, R | 1 |
| Biton, V; Halford, JJ; Rosenfeld, WE; Sander, JW; Steinhoff, BJ; Toledo, M | 1 |
| Privitera, M; Richy, FF; Schabert, VF | 1 |
| Brigo, F; Del Giovane, C; Lattanzi, S; Russo, E; Silvestrini, M; Striano, P; Trinka, E; Zaccara, G | 1 |
| Elliott, T; Gienapp, AJ; Ridley-Pryor, T; Wheless, JW | 1 |
| Karkare, S; Kothare, SV; Shah, YD; Varughese, RT | 1 |
| Ferrari, L; Kamin, M; Rosenfeld, WE | 1 |
| Abou-Khalil, B; Aboumatar, S; Klein, P; Krauss, GL; Rosenfeld, WE; Sperling, MR | 1 |
| Ben-Menachem, E; Brandt, C; García Morales, I; Rosenfeld, WE; Santamarina, E; Serratosa, JM; Steinhoff, BJ | 1 |
| Aboumatar, S; Biton, V; Ferrari, L; Rosenfeld, WE; Wechsler, R | 1 |
| Charlier, B; Coglianese, A; Coppola, G; Dal Piaz, F; de Grazia, U; Filippelli, A; Izzo, V; Menna, P; Operto, FF | 1 |
| Fornari Caprara, AL; Rissardo, JP | 1 |
| Dhir, A | 1 |
| Ferrari, L; Nisman, A; Pegan, A; Ursino, J | 1 |
| Aboumatar, S; Borchert, L; Gelfand, M; Halford, JJ; Kamin, M; Klein, P; Krauss, GL; Rosenfeld, WE; Sperling, MR; Vossler, DG; Wechsler, R | 1 |
| Chung, SS; French, JA; Kamin, M; Kowalski, J; Krauss, GL; Lee, SK; Maciejowski, M; Mizne, S; Rosenfeld, WE; Sperling, MR | 1 |
| Brigo, F; Del Giovane, C; Lattanzi, S; Silvestrini, M; Striano, P; Trinka, E; Zaccara, G | 1 |
| Steinhoff, BJ | 1 |
| Campbell, A; Guignet, M; White, HS | 1 |
| Główka, FK; Karaźniewcz-Łada, M; Sommerfeld-Klatta, K; Zielińska-Psuja, B | 1 |
| Coe, P; Elizebath, R; Gutierrez, EG; Krauss, GL; Yang, J; Zhang, E | 1 |
| Cutillo, G; Hirsch, LJ; Tolba, H | 1 |
| Ferrari, L; Nisman, A; Rosenfeld, WE | 1 |
| Wang, C; Wang, J; Zhang, L | 1 |
| Klein, P; Löscher, W | 1 |
| Chung, SS; French, JA; Kamin, M; Krauss, GL; Lee, SK; Maciejowski, M; Rosenfeld, WE; Sperling, MR | 1 |
| Bartholini, G; Depoortere, H; Lloyd, KG; Sanger, D; Zivkovic, B | 1 |
12 review(s) available for 2,3,4,6-tetrachlorophenol and Seizures
| Article | Year |
|---|---|
Is Cenobamate the Breakthrough We Have Been Wishing for?
Topics: Anticonvulsants; Carbamates; Chlorophenols; Epilepsy; Humans; Seizures; Tetrazoles | 2021 |
Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lacosamide; Male; Middle Aged; Network Meta-Analysis; Nitriles; Pyridones; Pyrrolidinones; Randomized Controlled Trials as Topic; Seizures; Tetrazoles | 2022 |
Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature.
Topics: Animals; Carbamates; Chlorophenols; Drug Resistant Epilepsy; Seizures; Tetrazoles; United States | 2023 |
Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Therapy, Combination; Epilepsy; Humans; Randomized Controlled Trials as Topic; Seizures; Tetrazoles; Treatment Outcome | 2020 |
Cenobamate (Xcopri) for focal seizures.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Seizures; Tetrazoles | 2020 |
[Cenobamate-a new perspective for epilepsy treatment].
Topics: Anticonvulsants; Carbamates; Chlorophenols; Epilepsy; Humans; Seizures; Tetrazoles | 2021 |
Cenobamate (XCOPRI): Can preclinical and clinical evidence provide insight into its mechanism of action?
Topics: Animals; Anticonvulsants; Carbamates; Chlorophenols; Drug Evaluation, Preclinical; Humans; Randomized Controlled Trials as Topic; Seizures; Tetrazoles | 2020 |
New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs).
Topics: Anticonvulsants; Carbamates; Chlorophenols; Drug Monitoring; Humans; Seizures; Tetrazoles | 2020 |
Anti-seizure medications and efficacy against focal to bilateral tonic-clonic seizures: A systematic review with relevance for SUDEP prevention.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Epilepsy, Tonic-Clonic; Humans; Seizures; Sudden Unexpected Death in Epilepsy; Tetrazoles | 2021 |
Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Dizziness; Dose-Response Relationship, Drug; Drug Resistant Epilepsy; Fatigue; Humans; Nausea; Randomized Controlled Trials as Topic; Seizures; Tetrazoles; Treatment Outcome; Vertigo | 2021 |
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
Topics: Animals; Anticonvulsants; Bromides; Carbamates; Chlorophenols; Drug Therapy, Combination; Epilepsy; Humans; Salts; Seizures; Tetrazoles; Treatment Outcome | 2021 |
8 trial(s) available for 2,3,4,6-tetrachlorophenol and Seizures
| Article | Year |
|---|---|
Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Humans; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Onset of efficacy and adverse events during Cenobamate titration period.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Therapy, Combination; Epilepsies, Partial; Humans; Quality of Life; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Humans; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Seizures; Tetrazoles; Treatment Outcome; Young Adult | 2020 |
Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Seizures; Tetrazoles; Young Adult | 2020 |
Cenobamate treatment of focal-onset seizures: Quality of life and outcome during up to eight years of treatment.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Chlorophenols; Humans; Quality of Life; Seizures; Tetrazoles; Treatment Outcome | 2021 |
Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Humans; Seizures; Tetrazoles; Treatment Outcome | 2021 |
Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Humans; Seizures; Tetrazoles; Treatment Outcome | 2021 |
10 other study(ies) available for 2,3,4,6-tetrachlorophenol and Seizures
| Article | Year |
|---|---|
Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Humans; Seizures; Tetrazoles; Treatment Outcome | 2021 |
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Humans; Seizures; Tetrazoles; Treatment Outcome | 2021 |
Initial Real-World Experience With Cenobamate in Adolescents and Adults: A Single Center Experience.
Topics: Adolescent; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Retrospective Studies; Seizures; Tetrazoles; Treatment Outcome; Young Adult | 2022 |
Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Child; Chlorophenols; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Humans; Retrospective Studies; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Caffeine; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Seizures; Tetrazoles; Treatment Outcome; Young Adult | 2022 |
Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Humans; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Development and Validation of a UHPLC-MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples.
Topics: Carbamates; Chlorophenols; Chromatography, High Pressure Liquid; Humans; Seizures; Tandem Mass Spectrometry | 2022 |
Cenobamate for the treatment of focal epilepsy.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Epilepsies, Partial; Humans; Seizures; Tetrazoles | 2020 |
An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes.
Topics: Administration, Oral; Anticonvulsants; Carbamates; Chlorophenols; Enteral Nutrition; Humans; Seizures; Tablets; Tetrazoles | 2020 |
Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Bicuculline; Chlorophenols; Clomipramine; Depressive Disorder; Disease Models, Animal; gamma-Aminobutyric Acid; Imipramine; Male; Olfactory Bulb; Rats; Receptors, GABA-A; Seizures; Sleep | 1987 |